BSECompany Update3h ago · 20 Aug 2026, 12:14 pm
Transcript of Conference Call for Investors and Analyst
Gem Aromatics Ltd · 544491
✦ AI SummaryResults
Gem Aromatics Ltd has released the transcript of its Q1 FY27 earnings conference call, highlighting Y-o-Y growth in revenue from operations, despite seasonal softness and impact from floods in Madagascar affecting raw material availability and pricing.
Analysis Scores
Earnings Impact6/10
Growth Catalyst4/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gem Aromatics Ltd - 544491 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Attachments (1)
📄pdf
Download →
4d6b3b7d-7209-406b-8231-449d8ff18a3e.pdf
View document text
Manufacturer & Exporters of Essential Oils & Aromatics Chemicals
Registered Office: A/410-411, A-Wing, Kailash Ind. Complex, Powai Vikhroli link Rd, Vikhroli West,
Mumbai-400079. Maharashtra, India, Tel No: +91-2225185231/25185931
CIN: L24246MH1997PLC111057
Date: August 20, 2026
To, To,
Listing / Compliance Department Listing / Compliance Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G
Dalal Street, Mumbai – 400 001 Bandra Kurla Complex
Bandra (E), Mumbai – 400 051
BSE CODE: 544491 NSE SYMBOL: GEMAROMA
Dear Sir/ Madam,
Subject: Transcript of Conference Call for Investor and Analysts
Pursuant to Regulation 30 and Para A of Part A of Schedule III and Regulation 46 of SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the transcript
of the conference call for investors and analysts on the Q1 FY27 results held virtually by the Company
on Friday, August 14, 2026.
This intimation is also being uploaded on the Company’s website at www.gemaromatics.com.
You are requested to take the same on your record.
Thanking you,
Yours faithfully,
For Gem Aromatics Limited
Akshita Deepak Gohil
Company Secretary & Compliance Officer
Encl: As Above
Corporate Office: A/503, Kailash Ind. Complex, Powai Vikhroli link Rd, Vikhroli (W), Mumbai, Maharashrta, India, Pin -
400079. Facility 1: Plot No 2, Survey No.16/4/2, Near Alok Industries, Village Rakholi, Silvassa, Dadra & Nagar Haveli, Pin -
396230.Facility 2: Khasara No 8,9,10,126, Village Gathona, Ujhani Budaun Road, District: Budaun, UP, India, Pin # 243639.
E-mail: secretarial@gemaromatics.in Web: www.gemaromatics.in
“Gem Aromatics Limited
Q1 FY27 Earnings Conference Call”
August 14, 2026
MANAGEMENT: MR. YASH PAREKH – MANAGING DIRECTOR AND CHIEF EXECUTIVE
OFFICER – GEM AROMATICS LIMITED
MR. AADIT SHAH – CEO’S OFFICE – GEM AROMATICS LIMITED
MODERATOR MR. AKHILESH GANDHI – STELLAR IR
Page 1 of 16
Gem Aromatics Limited
August 14, 2026
Moderator: Ladies and gentlemen, good day and welcome to the Q1 FY27 Conference Call
hosted by Gem Aromatics Limited.
As a reminder, all participant lines will be in the listen-only mode and there
will be an opportunity for you to ask questions after the presentation concludes.
Should you need assistance during this conference call, please signal an
operator by pressing star then zero on your touchtone phone. Please note that
this conference is being recorded.
I now hand the conference over to Mr. Akhilesh Gandhi from Stellar IR. Thank
you and over to you, Mr. Gandhi.
Akhilesh Gandhi: Thank you. Good evening, everyone. I, Akhilesh Gandhi, on behalf of Stellar
Investor Relations, welcome you all to the Gem Aromatics Q1 FY27 Earnings
Conference Call. We shall be sharing the key operating and financial highlights
for the first quarter ended on June 30, 2026.
Today, we have with us senior management team of Gem Aromatics Limited.
Mr. Yash Parekh, he is the Managing Director and CEO. With him, we have
Mr. Aadit Shah, he is from the CEO’s office.
Before we begin, I would like to state that this call may contain some of the
forward-looking statements, which are completely based upon the company’s
beliefs, opinions, and expectations as of today.
The statements made in today’s call are not a guarantee of future performance
and also involve unforeseen risks and uncertainties. The company also
undertakes no obligation to update any forward-looking statements to reflect
development that occur after the statement is made. Document related to
company’s financial performance, including press release and investor
presentation, has already been uploaded on the stock exchange.
With that, now I invite Mr. Yash to share his opening remarks on the
company’s performance for the first quarter. Thank you and over to you.
Yash Parekh: Good afternoon, everyone and a warm welcome to Gem Aromatics Earnings
Conference Call for the first quarter of FY27. On behalf of the management
team, I would like to thank all our investors, analysts, and stakeholders for
joining us today and for your continued trust and support.
Page 2 of 16
Gem Aromatics Limited
August 14, 2026
Q1 FY27 witnessed Y-o-Y growth in revenue from operations, reflecting
continued progress in the underlying business. At the same time, Q1 is
seasonally a softer quarter and should be viewed in that context. During the
quarter, our clove business was impacted by floods in Madagascar from where
we source raw materials, which affected raw material availability and pricing
as well as sales.
A key focus during the quarter was the continued progress at our Dahej facility
under Krystal Ingredients Private Limited. The facility is moving into the next
phase of operations with the focus now on strengthening core customer
engagement and expanding commercial opportunities across the newer product
categories. Over the past years, we have made significant investments in
expanding our manufacturing and product capabilities. A key part of our long-
term strategy is to reduce our dependence on the traditional mint portfolio and
build a more balanced mix across non-mint and higher value specialty
products.
Innovation and R&D remain important enablers of this strategy. With the
continued focus on process, innovation, product customization, and
development of higher value specialty molecules, our multipurpose
manufacturing platform at Dahej also provides flexibility to respond to
evolving customer requirements across different specialty chemistries,
supporting our ability to build a broader specialty product portfolio. In addition
to this, we have also had a strong R&D pipeline of new aroma chemicals
products that are ready and many of them have been executed and are in
different stages of execution.
We are now continuing to strengthen our international presence. The company
has approved the incorporation of a Brazil subsidiary, representing another step
towards expanding our distribution reach in Latin America and creating a
dedicated platform for our essential oils, aromatic chemicals, and specialty
chemicals. Overall, we remain focused on disciplined execution, strengthening
the capabilities built over the past few years.
As we progress through the next phase of our expansion, our focus will remain
on building a more diversified business, deepening the customer relationships,
and creating a sustainable long-term value. With that, I will now hand over the
Page 3 of 16
Gem Aromatics Limited
August 14, 2026
call to Mr. Aadit Shah from the CEO’s office for a detailed discussion of the
financial performance for the quarter. Thank you.
Aadit Shah: Thank you. I will now take you through the financial performance for the first
quarter of FY ‘27. Revenue from operations for the quarter stood at INR83
crores on a standalone basis compared to INR76 crores in Q1 FY ‘26. On a
consolidated basis, the revenue stood at INR99 crores compared to INR88
crores in Q1 FY ‘26. The revenue performance was supported by improving
business activity while Q1 is a seasonally softer quarter.
Moving to profitability, on a standalone basis, gross profit stood at INR14.7
crores while at a gross margin of 17.7%, while EBITDA stood at INR8.5 crores
with an EBITDA margin of 10.3%. On consolidated basis, gross profit stood
at INR16.5 crores with a gross margin of 16.7%, while EBITDA stood at
INR3.3 crores with an EBITDA margin of 3.3%.
The gross margin and EBITDA margin performance during the quarter were
impacted primarily by the product mix along with a higher raw material cost
in the clove business following the supply disruption in Madagascar. In
addition, the new plant carried a higher operating cost base while the newer
product verticals are still progressing through their commercialization cycle
and have not yet reached their full revenue potential.
Moving to profitability, standalone PAT stood at INR7.3 crores during the
quarter, while on a consolidated basis, the company reported
[Showing first 8,000 characters — download PDF for full document]